Literature DB >> 17825086

Multipotent mesenchymal stem cells from adult human eye conjunctiva stromal cells.

Samad Nadri1, Masoud Soleimani, Jafar Kiani, Amir Atashi, Reza Izadpanah.   

Abstract

Identification of mesenchymal stem cells (MSCs) derived from alternative sources has provided an exciting prospect for intensive investigation. This work focused on characterizing a new source of MSCs from stromal cells from human eye conjunctiva. In this study, after conjunctiva biopsies and culture of stromal segment of this tissue, fibroblast-like (SH2+, SH3+, CD29+, CD44+, CD166+, CD13+) human stromal cells, which can be differentiated toward the osteogenic, adipogenic, chondrogenic, and neurogenic lineages, were obtained. These cells expressed Oct-4, Nanog, Rex-1 genes, and some lineage-specific markers like cardiac actin and Keratin. Taken together, the results indicate that conjunctiva stromal-derived cells are a new source of multipotent MSCs and despite originating from an adult source, they express undifferentiated stem cell markers.

Entities:  

Mesh:

Year:  2007        PMID: 17825086     DOI: 10.1111/j.1432-0436.2007.00216.x

Source DB:  PubMed          Journal:  Differentiation        ISSN: 0301-4681            Impact factor:   3.880


  12 in total

Review 1.  Cell Therapy of Corneal Diseases.

Authors:  Winston W-Y Kao; Vivien J Coulson-Thomas
Journal:  Cornea       Date:  2016-11       Impact factor: 2.651

2.  Identification of a bone marrow-derived mesenchymal progenitor cell subset that can contribute to the gastric epithelium.

Authors:  Tomoyuki Okumura; Sophie S W Wang; Shigeo Takaishi; Shui Ping Tu; Vivian Ng; Russell E Ericksen; Anil K Rustgi; Timothy C Wang
Journal:  Lab Invest       Date:  2009-10-19       Impact factor: 5.662

3.  High yield of cells committed to the photoreceptor-like cells from conjunctiva mesenchymal stem cells on nanofibrous scaffolds.

Authors:  Samad Nadri; Bahram Kazemi; Mohamadreza Baghaban Eslaminejad; Mohamadreza Baghaban Eeslaminejad; Shahin Yazdani; Masoud Soleimani
Journal:  Mol Biol Rep       Date:  2013-04-16       Impact factor: 2.316

Review 4.  Recent progress on tissue-resident adult stem cell biology and their therapeutic implications.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Stem Cell Rev       Date:  2008       Impact factor: 5.739

5.  Cell therapy of congenital corneal diseases with umbilical mesenchymal stem cells: lumican null mice.

Authors:  Hongshan Liu; Jianhua Zhang; Chia-Yang Liu; I-Jong Wang; Martin Sieber; John Chang; James V Jester; Winston W Y Kao
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

6.  Role of poly-L-lysine-coated plates and fetal calf serum concentration in sheep chondroprogenitor cell culturing.

Authors:  Amir Atashi; Samad Nadri; Maryam Hafizi; Masoud Soleimani
Journal:  J Artif Organs       Date:  2009-06-18       Impact factor: 1.731

7.  Influence of adriamycin on changes in Nanog, Oct-4, Sox2, ARID1 and Wnt5b expression in liver cancer stem cells.

Authors:  Ding Sun; Lei Qin; Yang Xu; Jian-Xia Liu; Li-Ping Tian; Hai-Xin Qian
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

Review 8.  Dry Eye Management: Targeting the Ocular Surface Microenvironment.

Authors:  Xiaobo Zhang; Vimalin Jeyalatha M; Yangluowa Qu; Xin He; Shangkun Ou; Jinghua Bu; Changkai Jia; Junqi Wang; Han Wu; Zuguo Liu; Wei Li
Journal:  Int J Mol Sci       Date:  2017-06-29       Impact factor: 5.923

9.  Retinal pigment epithelium culture;a potential source of retinal stem cells.

Authors:  Hassan Akrami; Zahra-Soheila Soheili; Keynoush Khalooghi; Hamid Ahmadieh; Mojgan Rezaie-Kanavi; Shahram Samiei; Malihe Davari; Shima Ghaderi; Fatemeh Sanie-Jahromi
Journal:  J Ophthalmic Vis Res       Date:  2009-07

10.  Renewal of the Holocrine Meibomian Glands by Label-Retaining, Unipotent Epithelial Progenitors.

Authors:  Geraint J Parfitt; Phillip N Lewis; Robert D Young; Alex Richardson; J Guy Lyons; Nick Di Girolamo; James V Jester
Journal:  Stem Cell Reports       Date:  2016-08-11       Impact factor: 7.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.